The Tips Below are Knowledge-based, Non-Conventional Therapies, shared by a 3 time cancer survivor commented on a long-term multiple myeloma (MM) survivor. I am a long-term MM survivor and MM cancer coach.
Continue readingMultiple Myeloma Patients, Survivors and Caregivers Need More Than Conventional, FDA approved Surgery, Chemotherapy and Radiation. They Need Mind-Body Therapy If it’s one thing that I’ve
Continue reading“his team reports that human stem cells (HSC) residing in the end (trabecular region) of the bones display the highest regenerative ability of the blood and immune system…” I consider
Continue reading“…new treatment formulation delivered through a skin patch, maintaining an optimal blood level of the medicine (revlimid) for prolonged periods of time.” Low-dose multiple myeloma maintenance
Continue reading“our results reveal the effects of celastrol on proteasome activity in Multiple Myeloma cells and shed light on the underlying mechanisms of its anticancer activity…” Where is it written
Continue reading“Managing your health care records can be complicated, especially if you’re juggling information from several different medical providers and other sources…” Yet another example of
Continue readingCOLUMBUS, Ohio – A psychological intervention program designed for breast cancer patients reduces the risk of dying if the cancer recurs, new research shows. The study is the latest in a series
Continue readingfor patients with high-risk MM who have a poor long-term prognosis, allo-SCT may be a strong consideration in their initial course of therapy or in first relapse after chemotherapy I am a long-term MM
Continue reading“…achieving CR after HDT/SCT (ASCT) is the most important prognostic factor in Multiple Myeloma, even after long-term follow-up…” David, I have had full blown multiple myeloma
Continue readingExercise may have yet another benefit – the right amount at the right time could make multiple myeloma (MM) treatments such as radiation and chemotherapy more effective…” The many studies
Continue readingHowever, over time, patients with multiple myeloma incur more OOP costs. Accumulated OOP costs for 3 years following diagnosis was $9127 for patients with multiple myeloma. First some bad news and then
Continue reading“daratumumab was approved for use in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation” There’s
Continue reading